Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELX-02 in Cystic Fibrosis with G542X Allele
NCT04135495Phase 2Completed
- Start
- Nov 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of exaluren in cystic fibrosis (CF). Started Nov 2019; status: completed.
02
Drugs
exaluren
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04135495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04135495.